Abiracure 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Emcure Pharmaceuticals Ltd
  4. Abiracure 250 mg Tablet

Abiracure 250 mg Tablet

Abiracure 250 mg Tablet contains abiraterone acetate and is an oral anticancer medicine used in the treatment of prostate cancer. It works by reducing androgen production, which can help slow the growth of hormone-sensitive prostate cancer cells. The tablet is manufactured by Emcure Pharmaceuticals Ltd and is available as a prescription medicine.

BUY NOW

Category

Abiraterone acetate inhibits the CYP17 enzyme involved in androgen production in the body. It is used in adult men with advanced prostate cancer as part of an appropriate treatment regimen. The medicine is commonly administered with a corticosteroid and other androgen-deprivation treatment according to the prescribed protocol. Liver function, blood pressure, potassium levels, and other clinical parameters may require regular monitoring during treatment.

Technical Specification

Specification Details
Active Ingredient Abiraterone Acetate
Strength 250 mg
Dosage Form Tablet
Pack Size 120 tablets
Route of Administration Oral
Manufacturer Emcure Pharmaceuticals Ltd

Product Also Known As

Abiracure 250 mg, Abiracure 250 mg Tablet, Abiraterone Acetate 250 mg Tablet, Abiraterone 250 mg Tablet, Abiraterone Acetate Tablets, Prostate Cancer Tablet, Androgen Biosynthesis Inhibitor